Approved Cosmetic Uses: Xeomin is approved by the Food and Drug Administration to improve moderate-to-severe frown lines between the eyebrows (also known as glabellar lines) in adults. Xeomin is manufactured by Merz Pharmaceuticals.

Mode of Action: The active ingredient in Xeomin, botulinum toxin type A, paralyzes the muscles that cause wrinkles.

Courtesy of AAFPRS

Results: The wrinkle-smoothing results seen with Xeomin typically last up to six months. Results are visible within one week.

Side effects: Xeomin side effects or injection complications may include bleeding or bruising. Allergic reactions may also occur with Xeomin.

Like all other botulinum products, Xeomin poses a rare risk for spreading outside of the injection site. If this occurs, life-threatening swallowing and breathing problems may result. Of note, this side effect has not been seen in people receiving neurotoxins for cosmetic reasons.